These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 22111823

  • 1. Impact of free light chain hemodialysis in myeloma cast nephropathy: a case-control study.
    Peters NO, Laurain E, Cridlig J, Hulin C, Cao-Huu T, Frimat L.
    Hemodial Int; 2011 Oct; 15(4):538-45. PubMed ID: 22111823
    [Abstract] [Full Text] [Related]

  • 2. Haemodialysis using high cut-off dialysers for treating acute renal failure in multiple myeloma.
    Martín-Reyes G, Toledo-Rojas R, Torres-de Rueda Á, Sola-Moyano E, Blanca-Martos L, Fuentes-Sánchez L, Martínez-Esteban MD, Díez-de los Ríos MJ, Bailén-García A, González-Molina M, García-González I.
    Nefrologia; 2012 Oct; 32(1):35-43. PubMed ID: 22294003
    [Abstract] [Full Text] [Related]

  • 3. Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial.
    Bridoux F, Carron PL, Pegourie B, Alamartine E, Augeul-Meunier K, Karras A, Joly B, Peraldi MN, Arnulf B, Vigneau C, Lamy T, Wynckel A, Kolb B, Royer B, Rabot N, Benboubker L, Combe C, Jaccard A, Moulin B, Knebelmann B, Chevret S, Fermand JP, MYRE Study Group.
    JAMA; 2017 Dec 05; 318(21):2099-2110. PubMed ID: 29209721
    [Abstract] [Full Text] [Related]

  • 4. Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis.
    Hutchison CA, Heyne N, Airia P, Schindler R, Zickler D, Cook M, Cockwell P, Grima D.
    Nephrol Dial Transplant; 2012 Oct 05; 27(10):3823-8. PubMed ID: 22273664
    [Abstract] [Full Text] [Related]

  • 5. Paraprotein-Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy.
    Finkel KW, Cohen EP, Shirali A, Abudayyeh A, American Society of Nephrology Onco-Nephrology Forum.
    Clin J Am Soc Nephrol; 2016 Dec 07; 11(12):2273-2279. PubMed ID: 27526708
    [Abstract] [Full Text] [Related]

  • 6. Management options for cast nephropathy in multiple myeloma.
    Cockwell P, Hutchison CA.
    Curr Opin Nephrol Hypertens; 2010 Nov 07; 19(6):550-5. PubMed ID: 20827195
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment by long haemodialysis sessions with high cut-off filters in myeloma cast nephropathy: our experience.
    Borrego-Hinojosa J, Pérez-del Barrio MP, Biechy-Baldan Mdel M, Merino-García E, Sánchez-Perales MC, García-Cortés MJ, Ocaña-Pérez E, Gutiérrez-Rivas P, Liébana-Cañada A.
    Nefrologia; 2013 Nov 07; 33(4):515-23. PubMed ID: 23897183
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of IHD with Adsorptive PMMA Membrane in Myeloma Cast Nephropathy: A Cohort Study.
    Sens F, Chaintreuil D, Jolivot A, Guebre-Egziabher F, Robinson P, Karlin L, Bridoux F, Juillard L.
    Am J Nephrol; 2017 Nov 07; 46(5):355-363. PubMed ID: 29017155
    [Abstract] [Full Text] [Related]

  • 10. Treatment of acute kidney injury with cast nephropathy.
    Walther C, Podoll AS, Finkel KW.
    Clin Nephrol; 2014 Jul 07; 82(1):1-6. PubMed ID: 24725380
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Therapeutic Efficacy and Cost Effectiveness of High Cut-Off Dialyzers Compared to Conventional Dialysis in Patients with Cast Nephropathy.
    Curti A, Schwarz A, Trachsler J, Tomonaga Y, Ambühl PM.
    PLoS One; 2016 Jul 07; 11(7):e0159942. PubMed ID: 27467401
    [Abstract] [Full Text] [Related]

  • 15. Differential progression of renal scarring and determinants of late renal recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney.
    Basnayake K, Cheung CK, Sheaff M, Fuggle W, Kamel D, Nakoinz S, Hutchison CA, Cook M, Stoves J, Bradwell AR, Cockwell P.
    J Clin Pathol; 2010 Oct 07; 63(10):884-7. PubMed ID: 20876319
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis.
    Hutchison CA, Bradwell AR, Cook M, Basnayake K, Basu S, Harding S, Hattersley J, Evans ND, Chappel MJ, Sampson P, Foggensteiner L, Adu D, Cockwell P.
    Clin J Am Soc Nephrol; 2009 Apr 07; 4(4):745-54. PubMed ID: 19339414
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy.
    Hasegawa M, Kondo F, Yamamoto K, Murakami K, Tomita M, Nabeshima K, Nakai S, Kato M, Ohashi A, Arai J, Hiki Y, Ishii J, Emi N, Sugiyama S, Yuzawa Y.
    Ther Apher Dial; 2010 Oct 07; 14(5):451-6. PubMed ID: 21175542
    [Abstract] [Full Text] [Related]

  • 19. The rationale and evidence base for the direct removal of serum-free light chains in the management of myeloma kidney.
    Cockwell P, Cook M.
    Adv Chronic Kidney Dis; 2012 Sep 07; 19(5):324-32. PubMed ID: 22920643
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.